|
M.V. Leonova
Clinically significant drug interactions with warfarin: bleeding risk
|
№13 / 2022
|
|
D.I. Trukhan, D.S. Ivanova
Drug safety in real clinical practice: focus on protective therapy
|
№3 / 2022
|
|
I.G. Pakhomova (1), I.V. Gubonina (2)
NSAID-INDUCED PATHOLOGY OF THE GASTROINTESTINAL TRACT: WHAT IS REMAINING IN THE SHADOW?
|
№s5-17 / 2017
|
|
N.P. Lyamina, E.S. Karpova
CARDIOVASCULAR SAFETY AND EFFICACY OF CELECOXIB: FOCUS ON TREATMENT AND CARDIOSOMATIC REHABILITATION
|
№15 / 2017
|
|
E.N. Sukhikh, O.V. Simonova
CONCENTRATIONS OF STABLE METABOLITES OF NITRIC OXIDE IN THE SERUM AND URINE OF PATIENTS WITH ANKILOSING SPONDYLOARTHRITIS
|
№7 / 2017
|
|
I.A. Zolotovskaya (1), I.L. Davydkin (1), N.Yu. Borovkova (2)
THERAPY WITH NONSTEROID ANTI-INFLAMMATORY DRUGS IN PATIENTS WITH ACUTE NONSPECIFIC LOW BACK PAIN: DYNAMICS OF RENAL FUNCTION: RESULTS OF “PANDA” COGORT STUDY
|
№7 / 2017
|
|
N.A. Shostak, A.A. Klimenko, D.A. Anichkov, A.A. Kondrashov
NEW MECHANISMS OF ACTION OF NSAIDS: FOCUS ON CARDIOVASCULAR SAFETY
|
№19 / 2016
|
|
N.V. Chichasova
OSTEOARTHROSIS AND COMORBIDITY: PROBLEM OF CHOICE OF NSAIDS
|
№19 / 2015
|
|
M.V. Zhuravleva, A.A. Makhova, E.V. Shikh
PLACE OF MILGAMMA IN COMBINED THERAPY OF BACK PAIN SYNDROME
|
№19 / 2013
|
|
O.V. Yakob
IS IT POSSIBLE TO REDUCE THE RISK OF NSAID-INDUCED GASTROPATHY?
|
№19 / 2013
|
|
O.V. Kotova
THE USE OF KETOROLAC IN ACUTE PAIN SYNDROMES
|
№13 / 2013
|
|
P.R. Kamchatnov
Increased Effectiveness Of Analgetic Therapy In Degenerative Lesions Of The Spine
|
№14 / 2012
|
Русский
